Literature DB >> 25837029

Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension.

Wouter Jacobs1, Thelma C Konings2, Martijn W Heymans3, Anco Boonstra4, Harm Jan Bogaard4, Albert C van Rossum2, Anton Vonk Noordegraaf5.   

Abstract

Exclusion of pulmonary hypertension secondary to left-sided heart disease (left heart failure (LHF)) is pivotal in the diagnosis of pulmonary arterial hypertension (PAH). In case of doubt, invasive measurements are recommended. The aim of the present study was to investigate whether it is possible to diagnose LHF using noninvasive parameters in a population suspected of PAH.300 PAH and 80 LHF patients attended our pulmonary hypertension clinic before August 2010, and were used to build the predictive model. 79 PAH and 55 LHF patients attended our clinic from August 2010, and were used for prospective validation.A medical history of left heart disease, S deflection in V1 plus R deflection in V6 in millimetres on ECG, and left atrial dilation or left valvular heart disease that is worse than mild on echocardiography were independent predictors of LHF. The derived risk score system showed good predictive characteristics: R(2)=0.66 and area under the curve 0.93. In patients with a risk score ≥72, there is 100% certainty that the cause of pulmonary hypertension is LHF. Using this risk score system, the number of right heart catheterisations in LHF may be reduced by 20%.In a population referred under suspicion of PAH, a predictive model incorporating medical history, ECG and echocardiography data can diagnose LHF noninvasively in a substantial percentage of cases.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25837029     DOI: 10.1183/09031936.00202814

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Decreased Peak Left Atrial Longitudinal Strain Is Associated with Persistent Pulmonary Hypertension Associated with Left Heart Disease.

Authors:  Ju-Hee Lee; Jae-Hyeong Park; In-Chang Hwang; Jin Joo Park; Jun-Bean Park
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

Review 2.  Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Authors:  Bhavadharini Ramu; Thenappan Thenappan
Journal:  Curr Heart Fail Rep       Date:  2016-04

3.  CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds.

Authors:  Benjamin J Currie; Chris Johns; Matthew Chin; Thanos Charalampopolous; Charlie A Elliot; Pankaj Garg; Smitha Rajaram; Catherine Hill; Jim W Wild; Robin A Condliffe; David G Kiely; Andy J Swift
Journal:  Int J Cardiol       Date:  2018-03-04       Impact factor: 4.164

Review 4.  Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Athanasios Charalampopoulos; Robert Lewis; Peter Hickey; Charlotte Durrington; Charlie Elliot; Robin Condliffe; Ian Sabroe; David G Kiely
Journal:  Front Med (Lausanne)       Date:  2018-06-06

5.  Pulmonary hypertension due to left heart disease.

Authors:  Jean-Luc Vachiéry; Ryan J Tedford; Stephan Rosenkranz; Massimiliano Palazzini; Irene Lang; Marco Guazzi; Gerry Coghlan; Irina Chazova; Teresa De Marco
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

6.  Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland.

Authors:  Harrison Stubbs; Alexander MacLellan; Michael McGettrick; Bhautesh Jani; Melanie Brewis; Colin Church; Martin Johnson
Journal:  Open Heart       Date:  2022-04

Review 7.  Left ventricular heart failure and pulmonary hypertension.

Authors:  Stephan Rosenkranz; J Simon R Gibbs; Rolf Wachter; Teresa De Marco; Anton Vonk-Noordegraaf; Jean-Luc Vachiéry
Journal:  Eur Heart J       Date:  2015-10-27       Impact factor: 29.983

Review 8.  Clinical update on pulmonary hypertension.

Authors:  Salim Yaghi; Anastasia Novikov; Theo Trandafirescu
Journal:  J Investig Med       Date:  2020-04-01       Impact factor: 2.895

9.  Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI.

Authors:  Christopher S Johns; James M Wild; Smitha Rajaram; Euan Tubman; David Capener; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; David G Kiely; Andrew J Swift
Journal:  Radiology       Date:  2018-07-03       Impact factor: 29.146

10.  Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score.

Authors:  Samara M A Jansen; Anna E Huis In 't Veld; Wouter Jacobs; Hans P Grotjohan; Marc Waskowsky; Jan van der Maten; Arno van der Weerdt; Romke Hoekstra; Maria J Overbeek; Sjoerd A Mollema; Peter Hans C G Tolen; Lahssan H Hassan El Bouazzaoui; Joris W J Vriend; J Milena M Roorda; Ramon de Nooijer; Ivo van der Lee; Bart A J Voogel; Kathinka Peels; Thomas Macken; Jacqueline M Aerts; Anton Vonk Noordegraaf; M Louis Handoko; Frances S de Man; Harm Jan Bogaard
Journal:  J Am Heart Assoc       Date:  2020-07-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.